GELESIS HOLDINGS, IN

GLS
End-of-day quote Nyse - 06:00 2022-12-05 pm EST
0.3700 USD -15.02%
Prev.0.43540000
Open0.43000100
High0.43000100
Low0.36010000
Volume59 260
Latest news
11/22
11/21
11/21
11/21
Chart GELESIS HOLDINGS, INC.
Financials
Sales 2022 28,5 M - -
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 21,2 M 21,2 M -
Capi. / Sales 2022 0,74x
Capi. / Sales 2023 0,41x
Nbr of Employees 101
Free-Float 47,6%
Company
Gelesis Holdings, Inc., formerly Capstar Special Purpose Acquisition Corp., is a commercial stage biotherapeutics company built for consumer engagement. The Company focuses on advancing superabsorbent hydrogel therapeutics for chronic gastrointestinal (GI) diseases including excess weight, type two...
Sector :
Other Pharmaceuticals
Calendar :
2023-03-23 Earnings Release

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 0,29 $
Average target price 0,45 $
Spread / Average Target 55,1%